StockNews.com Begins Coverage on Sientra (NASDAQ:SIEN)

Equities researchers at StockNews.com initiated coverage on shares of Sientra (NASDAQ:SIEN) in a research note issued on Tuesday. The firm set a “hold” rating on the medical instruments supplier’s stock.

Sientra Stock Performance

The firm’s 50-day moving average price is $0.46 and its 200-day moving average price is $1.20. Sientra has a 1 year low of $0.16 and a 1 year high of $4.94. The stock has a market capitalization of $2.08 million, a P/E ratio of -0.03 and a beta of 2.04.

Institutional Investors Weigh In On Sientra

Institutional investors have recently added to or reduced their stakes in the company. Mirabella Financial Services LLP purchased a new stake in shares of Sientra in the first quarter worth about $26,000. Advisor Group Holdings Inc. boosted its position in shares of Sientra by 230.9% in the first quarter. Advisor Group Holdings Inc. now owns 11,930 shares of the medical instruments supplier’s stock worth $26,000 after buying an additional 8,325 shares during the period. Evoke Wealth LLC boosted its position in shares of Sientra by 148.5% in the fourth quarter. Evoke Wealth LLC now owns 44,300 shares of the medical instruments supplier’s stock worth $27,000 after buying an additional 26,473 shares during the period. LPL Financial LLC purchased a new stake in shares of Sientra in the second quarter worth about $31,000. Finally, Wolverine Trading LLC purchased a new stake in shares of Sientra in the second quarter worth about $32,000. Hedge funds and other institutional investors own 15.38% of the company’s stock.

Sientra Company Profile

Sientra, Inc, a medical aesthetics company, develops and sells medical aesthetics products in the United States and internationally. It offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra Round, Sientra Teardrop, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names.